HRTX   $1.55  -3.73% Market Closed After Close 1.55 0.0

Heron Therapeutics Inc
Total Cash 67.35M
totalCashPerShare 0.444
EBITDA -26.02M
Total Debt 178.71M
quickRatio 1.756
currentRatio 2.38
Total Revenue 136.36M
debtToEquity
Revenue/Share 0.883
ROA -0.08582
ROE
grossProfits
freeCashflow 285.00K
operatingCashflow -20.84M
earningsGrowth
revenueGrowth 0.134
grossMargins 0.29763
ebitdaMargins -0.19082001
operatingMargins -0.17891
profitMargins -0.35294
enterpriseValue 379.82M
forwardPE inf
floatShares 115.83M
sharesOutstanding 151.67M
sharesShort 30.64M
sharesShortPriorMonth 35.44M
dateShortInterest
sharesPercentSharesOut 0.20%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.87%
Short Ratio help_outline 15.54%
shortPercentOfFloat 0.26%
impliedSharesOutstanding
bookValue -0.25
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -48.13M
trailingEps -0.25%
forwardEps 0.0
enterpriseToEbitda -14.60
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.03 3Q 2024
institutionsCount 224
lastUpdated Nov. 6, 2024, 5:24 p.m.